United States
Germany
Japan
United Kingdom
China
Carrier-free (BSA/glycerol-free) UCHL1 mouse monoclonal antibody, clone OTI8D2
| Applications | ELISA |
| Reactivities | Human |
Antibodies
Carrier-free (BSA/glycerol-free) UCHL1 mouse monoclonal antibody, clone OTI1D2
| Applications | ELISA |
| Reactivities | Human |
Carrier-free (BSA/glycerol-free) UCHL1 mouse monoclonal antibody, clone OTI2D10
| Applications | ELISA |
| Reactivities | Human |
Carrier-free (BSA/glycerol-free) UCHL1 mouse monoclonal antibody, clone OTI2G2
| Applications | ELISA |
| Reactivities | Human |
Carrier-free (BSA/glycerol-free) UCHL1 mouse monoclonal antibody, clone OTI1G7
| Applications | ELISA |
| Reactivities | Human |
Carrier-free (BSA/glycerol-free) MYBPC3 mouse monoclonal antibody, clone OTI1D1
| Applications | ELISA |
| Reactivities | Human |
Carrier-free (BSA/glycerol-free) NEFL mouse monoclonal antibody, clone OTI2D1
| Applications | ELISA |
| Reactivities | Human |
Carrier-free (BSA/glycerol-free) NEFL mouse monoclonal antibody, clone OTI5C8
| Applications | ELISA |
| Reactivities | Human |
Carrier-free (BSA/glycerol-free) IL-6 mouse monoclonal antibody, clone OTI10C5
| Applications | ELISA |
| Reactivities | Human |
Carrier-free (BSA/glycerol-free) NEFL mouse monoclonal antibody, clone OTI2C12
| Applications | ELISA |
| Reactivities | Human |
Carrier-free (BSA/glycerol-free) NEFL mouse monoclonal antibody, clone OTI6H2
| Applications | ELISA |
| Reactivities | Human |
Carrier-free (BSA/glycerol-free) ST2 mouse monoclonal antibody, clone OTI8G3
| Applications | ELISA |
| Reactivities | Human |
Carrier-free (BSA/glycerol-free) ST2 mouse monoclonal antibody, clone OTI2E9
| Applications | ELISA |
| Reactivities | Human |
Carrier-free (BSA/glycerol-free) ST2 mouse monoclonal antibody, clone OTI1D6
| Applications | ELISA |
| Reactivities | Human |
Carrier-free (BSA/glycerol-free) ST2 mouse monoclonal antibody, clone OTI21A7
| Applications | ELISA |
| Reactivities | Human |
活动过滤器
clear Category
-
Antibodies
- Primary Antibodies
优化搜索结果
Target Symbol
Applications
Knockout (KO) Validation
Conjugates
Brands
Pathways
- Hypertrophic cardiomyopathy (HCM) (40)
- Cytokine-cytokine receptor interaction (39)
- Graft-versus-host disease (25)
- Toll-like receptor signaling pathway (25)
- Pathways in cancer (24)
- Cytosolic DNA-sensing pathway (23)
- Hematopoietic cell lineage (23)
- Jak-STAT signaling pathway (23)
- NOD-like receptor signaling pathway (23)
- Prion diseases (23)
- Parkinson's disease (22)
- Dilated cardiomyopathy (17)
- Amyotrophic lateral sclerosis (ALS) (12)
- Cell adhesion molecules (CAMs) (7)
- T cell receptor signaling pathway (3)
- Allograft rejection (2)
- Antigen processing and presentation (2)
- Autoimmune thyroid disease (2)
- Systemic lupus erythematosus (2)
- Type I diabetes mellitus (2)
- Viral myocarditis (2)
- Acute myeloid leukemia (1)
- Bladder cancer (1)
- Chemokine signaling pathway (1)
- Chronic myeloid leukemia (1)
- Colorectal cancer (1)
- Endometrial cancer (1)
- ErbB signaling pathway (1)
- Focal adhesion (1)
- Glioma (1)
- Insulin signaling pathway (1)
- Long-term depression (1)
- Long-term potentiation (1)
- MAPK signaling pathway (1)
- Melanoma (1)
- Metabolic pathways (1)
- Natural killer cell mediated cytotoxicity (1)
- Neurotrophin signaling pathway (1)
- Non-small cell lung cancer (1)
- Pancreatic cancer (1)
- Progesterone-mediated oocyte maturation (1)
- Prostate cancer (1)
- Regulation of actin cytoskeleton (1)
- Renal cell carcinoma (1)
- Thyroid cancer (1)
- Vascular smooth muscle contraction (1)
- mTOR signaling pathway (1)
